Re: estrogen-progestin replacement therapy and endometrial cancer.
McKnight
B
B
Voigt
L F
LF
Beresford
S A
SA
Weiss
N S
NS
D004334:Drug Administration Schedule; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016017:Odds Ratio; D011372:Progestins / Q000008:administration & dosage*; D012306:Risk; D012307:Risk Factors
D004967:Estrogens; D011372:Progestins